Effect of Conjugated Linoleic Acid Intake on Liver and Kidney Function

NCT00449462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-07-06

No results posted yet for this study

Summary

The knowledge of the health effects of CLA on the human body is limited. However, CLA supplements are sold over the counter in several countries and various techniques are used to increase the content of CLA in food.

The CLAxon-study will be performed to investigate wether high doses of CLA can be safely given to healthy human volunteers.

Conditions

  • Healthy

Interventions

PROCEDURE

consumption of CLA enriched food

Sponsors & Collaborators

  • VU University of Amsterdam

    collaborator OTHER
  • Wageningen University

    lead OTHER

Principal Investigators

  • Ingeborg A Brouwer, PhD · VU University of Amsterdam

  • Martijn B Katan, Professor · VU University of Amsterdam

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-03-31
Completion
2007-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00449462 on ClinicalTrials.gov